The Globe and Mail reports in its Friday, Feb. 21, edition that National Bank Financial analyst Zachary Evershed has reaffirmed his "outperform" recommendation for DRI Healthcare Trust. The Globe's David Leeder writes in the Eye On Equities column that Mr. Evershed boosted his unit target to $17.50 from $15.50. Analysts on average target the units at $19.39. Mr. Evershed says in a note: "We revise our estimates, incorporating the latest consensus forecasts for marketer sales and the weakening CAD/USD. We also introduce our 2026 detailed forecasts; this has no impact on our target, which is driven by a long-term DCF. We nudge our Q4/24 profitability forecasts slightly lower as we expect some carryover of investigation expenses into the quarter, though not to the extent seen in Q3." The Globe reported on July 10 that Mr. Evershed said he was worried about the executive changes at DRI Healthcare. The units could then be had for $12.27. The Globe reported on Jan. 4 that CIBC Asset Management manager Craig Jerusalim had named DRI Healthcare a top pick for 2025. The units were then going for $11.72.